“…Studies comparing groups of women by HIV status using PCR-based methods have reported an HPV prevalence range of 40 to 77.4 percent for HIV-positive women and 14 to 62 percent for HIV-negative women (Ahdieh et al, 2001, Critchlow and Koutsky, 1995, Ellerbrock et al, 2000, Hankins et al, 1999, Langley et al, 1996, Maiman et al, 1998, Massad et al, 1999, Minkoff et al, 1998, Moscicki et al, 2000, Palefsky et al, 1999, Rezza et al, 1997, Shah et al, 1997, Silverberg et al, 2002, Sun et al, 1995, Sun et al, 1997, Temmerman et al, 1999, Wright et al, 1994a. A similar increase in prevalence has been observed in populations of HIV -positive men (Breese et al, 1995, Kiviat et al, 1993, Law et al, 1991, Palefsky et al, 1994. Renal allograft recipients also appear to be at an increased risk of HPV infection, with recipients demonstrating consistently higher prevalence of HPV 16 or 18 DNA than controls (Alloub et al, 1989, Fairley et al, 1994a, Ogunbiyi et al, 1994.…”